ATNM · Company research
Actinium Pharmaceuticals, Inc (ATNM): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1.11 | $37,688,088 | 1215088.0 | 3.309232480533927 | — | — | 1.0768025142857143 | 1.2437491914725101 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.